Full Portfolio Receptor Profiling Services
At INDIGO Biosciences, we provide an extensive suite of Receptor Profiling services, offering detailed insights into compound interactions across key receptor families. Our Full Panel Screens for Nuclear Receptors (NRs), G Protein-Coupled Receptors (GPCRs), and Growth Factors enable you to assess compound selectivity, identify off-target effects, and predict potential drug-drug interactions—empowering your drug development process.
Nuclear Receptor Profiling
Nuclear receptors regulate critical pathways, including metabolism, immune response, and development. Evaluating a compound across the entire nuclear receptor family provides insights into potential off-target interactions and ensures a comprehensive safety and efficacy profile.
Why Perform Full Panel Screens?
Nuclear receptor screens help determine:
- Drug selectivity and specificity.
- Potential interactions impacting metabolic pathways.
- Safety concerns related to hormonal or endocrine disruption.
Targets: PXR, CAR, AhR, ER, AR, FXR, PPAR, GR, and more.
GPCR Profiling
G Protein-Coupled Receptors represent the largest family of druggable targets, mediating diverse physiological processes such as cardiovascular function, neurological signaling, and immune responses.
Why Perform Full Panel Screens?
GPCR profiling helps identify:
- The primary therapeutic targets for your compound.
- Potential unintended effects on non-target GPCRs.
- Synergistic opportunities or risks in combination therapies.
Growth Factor Profiling
Growth factors regulate cell proliferation, differentiation, and survival and play a critical role in oncology, regenerative medicine, and inflammation research.
Why Perform Full Panel Screens?
Growth factor screens enable:
- Discovery of potential off-target effects that could influence cancer progression or tissue regeneration.
- Mechanistic studies to determine compound effects on cellular pathways.
- Early identification of toxicological concerns linked to growth dysregulation.
Applications: Oncology, wound healing, inflammation, obesity research.
Targets: EGFR, VEGFR, PDGFR, and more.
Why Perform Full Panel Screens?
Full panel screens provide a holistic evaluation of a compound’s activity across receptor families. By understanding its interaction profile, researchers can:
Enhance Safety
Identify and mitigate off-target effects early.
Optimize Efficacy
Discover specific receptor targets for enhanced therapeutic outcomes.
Improve Success Rates
Avoid late-stage failures by making informed decisions early in the pipeline.
Get Started with INDIGO’s Receptor Profiling Service
Step 1: Request a Quote in One Click
Fill out a Request a Quote form and tell us more about your study and objectives.
Step 2: Design Your Service Study with Our Scientists
Choose from our full-panel screens or select a profile of receptors tailored to your needs.
Step 3: Send Your Samples and Get Your Results
Provide your samples or compounds, and we will do the rest.
Receive a complete data package and clear study reports in record time!